AI Verdict
LUCD has stronger fundamentals based on our AI analysis.
LUCD vs LTRN Fundamental Comparison
| Metric | LUCD | LTRN |
|---|---|---|
| Revenue | $4.7M | N/A |
| Net Income | $-58.0M | $-17.1M |
| Net Margin | -1,232.7% | N/A |
| ROE | -530.4% | -262.0% |
| ROA | -143.4% | -155.1% |
| Current Ratio | 1.31x | 2.40x |
| Debt/Equity | 2.22x | 0.00x |
| EPS | $-0.59 | $-1.57 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
LUCD vs LTRN: Frequently Asked Questions
Is LUCD or LTRN a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LUCD has stronger fundamentals. LUCD is rated STRONG SELL (95% confidence) while LTRN is rated STRONG SELL (87% confidence). This is not investment advice.
How does LUCD compare to LTRN fundamentally?
Lucid Diagnostics Inc. has ROE of -530.4% vs Lantern Pharma Inc.'s -262.0%. Net margins are -1,232.7% vs N/A respectively.
Which stock pays higher dividends, LUCD or LTRN?
LUCD has a dividend yield of N/A or no dividend while LTRN has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in LUCD or LTRN for long term?
For long-term investing, consider that LUCD has STRONG SELL rating with 95% confidence, while LTRN has STRONG SELL rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about LUCD vs LTRN?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For LUCD vs LTRN, the AI consensus favors LUCD based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.